Can personality traits influence eye side effects from glaucoma meds?

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll adults using or who have used glaucoma medications to see if personality traits relate to ocular adverse effects. Participants complete a questionnaire measuring five personality traits and provide basic demographics, while researchers review medical records for glaucoma medications and side effects. The study focuses on whether certain traits are associated with the occurrence or severity of side effects and if personality influences reporting or management of these events. No interventions are involved; data will be analyzed to identify potential associations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age 18 years or older.
* Diagnosis of glaucoma.
* Current or previous treatment with one or more glaucoma medications.
* Able to provide informed consent.
* Able to complete the study questionnaires in English or French.

Exclusion Criteria:

* Uncontrolled anxiety or depression that was present before glaucoma medication treatment began.
* Unable to provide informed consent.
* Unable to complete the study questionnaires in English or French.

Where it's running

• McGill University Health Center
  Montreal, Quebec, Canada Recruiting

Study contacts

• Principal investigator: Hady Saheb, MD MPH — Muhc Ri
• Study coordinator: Ana Hernandez, MD
• Email: ana.ramirezhernandez@mail.mcgill.ca
• Phone: 15149341934

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Balance training for people with glaucoma

  A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07910955

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

• Comparison of FT-1000 non-contact tonometry with Goldmann applanation tonometry in glaucoma patients

  This study tests whether the FT-1000 non-contact tonometer gives measurements that agree with the Goldmann applanation tonometer in adults with glaucoma.

  Recruiting Tomey Corporation · Jacksonville, Florida · NCT07804277

• Removing the ripcord from a glaucoma drainage device after 3 months

  This study tests whether removing the ripcord from an implanted glaucoma drainage device changes eye pressure for adults with open-angle glaucoma.

  Recruiting Duke University · Durham, North Carolina · NCT07803536

• Glaucoma and Brain Changes: How Brain Structure and Size See What Glaucoma Is Doing

  This study tests whether glaucoma is linked to broader brain changes by comparing brain MRI and eye health over time in people with glaucoma and matched controls.

  Recruiting University Hospital, Bordeaux · Bordeaux · NCT07802769

• Long-Term Results After Ab-interno Trabeculotomy for Glaucoma

  This study tests whether ab-interno trabeculotomy with the Trabectome can provide sustained intraocular pressure reduction in glaucoma patients who had the procedure between 2019 and 2021.

  Recruiting Wuerzburg University Hospital · Würzburg, Bavaria · NCT07780916

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.